Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Statistics

Total Valuation

SHE:301207 has a market cap or net worth of CNY 11.41 billion. The enterprise value is 9.08 billion.

Market Cap	11.41B
Enterprise Value	9.08B

Important Dates

The last earnings date was Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	Oct 27, 2025

Share Statistics

SHE:301207 has 595.00 million shares outstanding. The number of shares has decreased by -0.51% in one year.

Current Share Class	595.00M
Shares Outstanding	595.00M
Shares Change (YoY)	-0.51%
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	2.56%
Float	83.16M

Valuation Ratios

The trailing PE ratio is 62.36.

PE Ratio	62.36
Forward PE	n/a
PS Ratio	9.49
PB Ratio	2.00
P/TBV Ratio	2.01
P/FCF Ratio	32.83
P/OCF Ratio	31.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.46, with an EV/FCF ratio of 26.13.

EV / Earnings	49.64
EV / Sales	7.55
EV / EBITDA	30.46
EV / EBIT	57.88
EV / FCF	26.13

Financial Position

The company has a current ratio of 3.92

Current Ratio	3.92
Quick Ratio	3.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-61.52

Financial Efficiency

Return on equity (ROE) is 3.12% and return on invested capital (ROIC) is 5.11%.

Return on Equity (ROE)	3.12%
Return on Assets (ROA)	1.36%
Return on Invested Capital (ROIC)	5.11%
Return on Capital Employed (ROCE)	2.74%
Weighted Average Cost of Capital (WACC)	8.80%
Revenue Per Employee	1.61M
Profits Per Employee	244,545
Employee Count	748
Asset Turnover	0.17
Inventory Turnover	1.38

Taxes

In the past 12 months, SHE:301207 has paid 4.87 million in taxes.

Income Tax	4.87M
Effective Tax Rate	2.59%

Stock Price Statistics

The stock price has increased by +10.87% in the last 52 weeks. The beta is 0.83, so SHE:301207's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	+10.87%
50-Day Moving Average	20.32
200-Day Moving Average	19.41
Relative Strength Index (RSI)	46.14
Average Volume (20 Days)	5,286,453

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301207 had revenue of CNY 1.20 billion and earned 182.92 million in profits. Earnings per share was 0.31.

Revenue	1.20B
Gross Profit	935.56M
Operating Income	156.89M
Pretax Income	187.79M
Net Income	182.92M
EBITDA	298.11M
EBIT	156.89M
Earnings Per Share (EPS)	0.31

Balance Sheet

The company has 2.33 billion in cash and n/a in debt, with a net cash position of 2.33 billion or 3.91 per share.

Cash & Cash Equivalents	2.33B
Total Debt	n/a
Net Cash	2.33B
Net Cash Per Share	3.91
Equity (Book Value)	5.70B
Book Value Per Share	9.58
Working Capital	3.27B

Cash Flow

In the last 12 months, operating cash flow was 357.13 million and capital expenditures -9.70 million, giving a free cash flow of 347.43 million.

Operating Cash Flow	357.13M
Capital Expenditures	-9.70M
Depreciation & Amortization	141.22M
Net Borrowing	-300.00M
Free Cash Flow	347.43M
FCF Per Share	0.58

Margins

Gross margin is 77.80%, with operating and profit margins of 13.05% and 15.21%.

Gross Margin	77.80%
Operating Margin	13.05%
Pretax Margin	15.62%
Profit Margin	15.21%
EBITDA Margin	24.79%
EBIT Margin	13.05%
FCF Margin	28.89%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 3.13%.

Dividend Per Share	0.60
Dividend Yield	3.13%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	277.66%
Buyback Yield	0.51%
Shareholder Yield	3.64%
Earnings Yield	1.60%
FCF Yield	3.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 7, 2023
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	4